The Latin American breast implants market size is predicted to be worth USD 0.22 billion by 2028 from USD 0.16 billion in 2023, growing at a CAGR of 6.9% from 2023 to 2028.
The increasing prevalence of breast cancer is the primary factor influencing the growth of breast implants. Breast cancer cases across Latin American are on the rise, which is expected to boost the market during the forecast period. On the other hand, many women are interested in breast implantation treatments to have more shapely breasts. Therefore, breast implant demand in Latin America is expected to climb as women's desire to enlarge their breasts grows in the coming years.
Moreover, rising awareness of breast implant therapies is anticipated to enhance market growth throughout the forecast period. Breast implants are becoming more popular as the public's image of cosmetic surgery improves. On the other hand, the benefits like enhanced sexual and psychological well-being, improved lifestyle quality, and higher satisfaction with the appearance of the breasts propel the breast implants market to significant growth during the forecast period. More women are opting for breast augmentation treatments to change the size and shape of their breasts as their desire for a more pleasing appearance develops, fuelling the market growth.
Furthermore, promoting acceptance should minimize rippling and wrinkling advancements in breast implant technology, such as changes in material, design, and fill volumes. In addition, the market will advance as the demand for experienced plastic surgeons to undertake these procedures and provide helpful consultation to patients grows.
However, the breast implants market growth in the Latin American region is projected to be hampered in the future due to reasons such as high procedure costs and a rising risk of problems associated with breast implant surgery. In addition, in the coming years, scarring, rippling of breast implants, and other breast implant drawbacks are expected to have a negative impact on market growth.
This research report on the Latin American breast implants market has been segmented and sub-segmented into the following categories:
By Product:
By Shape:
By Application:
By End-Use:
By Country:
The Latin American breast implants market is expected to grow at a promising rate during the forecast period. The market growth is driven by the rising incidence of breast cancer, Breast implant market development, and improving healthcare infrastructure. Also, the market is predicted to grow as the number of cosmetic surgeries rises. Brazil, Mexico, and Argentina are expanding the Latin American regional market growth with a significant market share.
Growing regional markets such as Brazil and Mexico are estimated to present considerable development potential in the Latin American breast implants market. The rapid expansion of medical tourism, the growth of the adult population, and the increase in disposable income boost the demand for breast implants in these countries. As a result, Brazil is now ranked second in Latin America regarding the number of breast implant procedures performed. Brazil performed roughly 14.9 percent of breast implants surgeries in 2020.
For the majority of cosmetic operations, Brazil is the dominant rival. For example, breast augmentation is one of the most prevalent procedures in both countries, but Brazilians have pushed toward smaller implants.
During the forecast period, Mexico is most likely to have a significant share of the Latin American breast implants market. The breast implant market in Mexico is being fuelled by an increase in breast implant and breast augmentation treatments. In addition, breast implants are the most common cosmetic surgery operation for women who have had liposuction in Mexico.
KEY MARKET PLAYERS:
Companies playing a notable role in the Latin American breast implants market profiled in this report are AbbVie Inc. (Allergan plc), Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Johnson & Johnson (Mentor Worldwide LLC), Polytech Health & Aesthetics GmbH, Silimed, Sientra Inc., and Celaplas.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region